Vasopressin V2 Receptor Antagonist [EPC]

14926 reported adverse events

Drugs of this class: TOLVAPTAN

These side effects are most commonly reported by patients taking drugs of the Vasopressin V2 Receptor Antagonist [EPC] class:

# Side effect Count
0 DEATH 1042
1 THIRST 1011
2 OFF LABEL USE 888
3 RENAL IMPAIRMENT 884
4 CARDIAC FAILURE 828
5 PRODUCT DOSE OMISSION ISSUE 779
6 POLLAKIURIA 602
7 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 535
8 PRODUCT USE IN UNAPPROVED INDICATION 501
9 UNDERDOSE 498
See all common reactions for Vasopressin V2 Receptor Antagonist [EPC]

Drugs of the Vasopressin V2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RAPID CORRECTION OF HYPONATRAEMIA 205 0.8167
1 RENAL CYST RUPTURED 32 0.2370
2 URINE OSMOLARITY DECREASED 19 0.1557
3 POLYCYSTIC LIVER DISEASE 15 0.1415
4 RENAL CYST HAEMORRHAGE 29 0.1283
5 PULMONARY VEIN OCCLUSION 9 0.1111
6 RENAL CYST INFECTION 16 0.1006
7 LOW CARDIAC OUTPUT SYNDROME 30 0.0898
8 URINE OSMOLARITY INCREASED 12 0.0774
9 HYPERNATRAEMIA 367 0.0736
See all enriched reactions for Vasopressin V2 Receptor Antagonist [EPC]